Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in RDY — Dr Reddys Laboratories Ltd

CIK 902219 Boston, MA

Position in RDY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,362,476
+$674,251 QoQ
Shares Held
170,576
+41.9% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 0% Shared 4% None 96%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $3,311,744,758 across 31 Drug Manufacturers - Specialty & Generic names. RDY ranks #17 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RDY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,362,476 170,576
2025-12-31 $1,688,225 120,244
2025-09-30 $1,681,010 120,244
2025-06-30 $10,519,029 699,869
2025-03-31 $8,547,911 648,060
2024-12-31 $14,150,445 896,165
2024-09-30 $13,387,325 168,500
2024-06-30 $13,304,069 174,617
2024-03-31 $10,887,193 148,428
2023-12-31 $10,050,483 144,445
2023-09-30 $1,887,793 141,154
2023-06-30 $6,331,763 100,329
2023-03-31 $2,968,500 52,143
2022-12-31 $2,107,777 40,730
2022-09-30 $1,174,038 22,431
2022-06-30 $1,242,453 22,431
2022-03-31 $1,250,079 22,431
2021-03-31 $5,952,558 96,963
2020-12-31 $20,184,835 283,137
2020-09-30 $22,956,258 330,021
2020-06-30 $19,925,556 375,883
2020-03-31 $20,054,495 497,260